Cargando...
Strategies for Overcoming Resistance in Tumours Harboring BRAF Mutations
The development of resistance to previously effective treatments has been a challenge for health care providers and a fear for patients undergoing cancer therapy. This is an unfortunately frequent occurrence for patients undergoing targeted therapy for tumours harboring the activating V600E mutation...
Guardado en:
| Publicado en: | Int J Mol Sci |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
MDPI
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5372601/ https://ncbi.nlm.nih.gov/pubmed/28282860 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms18030585 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|